EQ (Equillium Bio) Short-Term Debt to Equity
The visualization of the market value of Equillium, Inc. (EQ) confirms the resilience of a business whose revenues rely on partner payments and remain independent of GDP phases. Equillium, Inc. minimizes risks by developing therapies for skin, lung, and kidney pathologies. The reliability of raw biological material supplies is ensured by proven counterparties and express logistics, with the indicator standing at 0.01.
%3A%20Short-Term%20Debt%20to%20Equity%20Ratio&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_EQ_-_Equillium-Inc._-_Short-Term-Debt-to-Equity-Ratio "Short-Term Debt to Capital: Equillium Bio (EQ) for 07/04/2022 - 10/31/2026 | 👁️GURU.Markets👁️")
Analytical breakdowns and data insights for company Equillium Bio (EQ)
- stock value and consensus price forecast:
- business market valuation indicators:
- balance sheet equity data:
- issuer credit burden and liquidity indicators:
Total Debt to Capital Equillium, Inc.|EQ - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Equillium, Inc.|EQ - Company Total Debt|Debt to Book Capitalization Ratio Equillium Inc|EQ - Company Long-Term Liabilities|Company Current Liabilities Equillium|Quick Liquidity equilliumbio.com
- earnings and market ratios statistics:
Fundamental company analysis:EQ Equillium
This indicator assesses the company's dependence on short-term liabilities relative to its own equity, determining the risk of liquidity loss during periods of rate volatility. The current value of 0.01 regarding short-term debt-to-equity confirms the low debt load of Equillium, Inc. (EQ), which is driven by the outsourcing of production and testing, sparing the business from the need to secure expensive express loans for infrastructure development.
Competitors of Equillium, Inc.
Short-Term Debt to Equity Argenx (ARGX)|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Abivax Pharma ABVX|ADMA - Short-Term Debt to Equity Ratio|Protagonist - Short-Term Debt to Capital|IMVT - Short-Term Debt to Capital|KNSA (Kiniksa Pharmaceuticals Ltd) - Short-Term Debt to Equity Ratio|Grifols Biemat - Ratio of Short-Term Indebtedness to Capital|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|celldex.com (CLDX) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Aurinia Pharmaceuticals Inc. (AUPH)|Short-Term Debt to Equity Ratio BioCryst Pharmaceuticals, Inc. BCRX|Short-Term Debt to Equity Vera Pharma VERA|DNTH - Short-Term Debt to Equity Ratio|PHVS: Short-Term Debt to Equity Ratio|ABCL - Short-Term Debt to Capital|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio PGEN|PHAR (Pharming) - Short-Term Debt to Capital|Current Liabilities to Capital Nektar Corp NKTR|Short-Term Debt to Capital UPB|ZBIO - Current Liabilities to Capital|Short-Term Debt to Equity Immunome IMNM|Short-Term Indebtedness to Equity Gossamer Bio Inc|KALV: Short-Term Debt to Equity Ratio|SEPN - Short-Term Debt to Capital|PVLA: Short-Term Debt to Capital|SVRA - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Rigel Pharmaceuticals, Inc.|Short-Term Debt to Equity ANAB|Short-Term Debt to Equity Astria Pharma (ATXS)|Short-Term Debt to Equity ENGN (enGene Corp)|Short-Term Debt to Capital RAPT (RAPT Therapeutics)|Short-Term Debt to Capital Coefficient Aerovate Therapeutics, Inc. (JBIO)|ACRS: Short-Term Debt to Equity Ratio|KYTX - Short-Term Debt to Capital|Tiziana Life Sciences PLC (TLSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Cabaletta Bio Inc|Short-Term Debt to Equity Ratio VTYX|THTX: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital AVTX|Short-Term Debt to Capital Coefficient Eledon Pharmaceuticals Inc.|Short-Term Debt to Equity Agenus Inc AGEN|CLYM: Short-Term Debt to Capital Ratio|Zura Bio - Short-Term Debt to Capital|atyrpharma.com (ATYR) - Short-Term Debt to Equity Ratio|ADAG (adagene.com) - Short-Term Debt to Equity Ratio|IMA - Short-Term Debt to Capital Coefficient|STTK (Shattuck Labs Inc) - Short-Term Debt to Capital|Current Liabilities to Capital Connect Pharma CNTB|Short-Term Debt to Equity Immunic, Inc. (IMUX)|atarabio.com (ATRA) - Short-Term Indebtedness to Equity|Short-Term Debt to Equity InflaRx IFRX|XFOR (X4 Pharmaceuticals Inc.) - Current Liabilities to Equity|Adicet - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital CELU (Celularity Inc.)|INMB: Short-Term Debt to Capital|barinthusbio.com (BRNS) - Short-Term Debt to Capital|Short-Term Debt to Equity Kezar Life Sciences, Inc.|SABS: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Akari Therapeutics plc (AKTX)|Short-Term Debt to Equity Ratio enlivex.com ENLV|Short-Term Debt to Capital QTTB (Q32 Bio)|Short-Term Debt to Capital geovax.com GOVX|EDSA: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital IBIO (iBio Inc)|CARM: Short-Term Debt to Capital|XTLB - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Bolt Biotherapeutics Inc.|Short-Term Debt to Equity Ratio HCW Biologics Inc (HCWB)|Short-Term Debt to Equity Aptevo Therapeutics (APVO)|Short-Term Debt to Equity Ratio aimimmuno.com AIM|Aditxt, Inc. - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital GRI Bio Corporation GRI|XRTX - Short-Term Debt to Equity|HIND (reshapelifesciences.com) - Short-Term Debt to Capital Ratio|REVB: Short-Term Debt to Capital|Current Liabilities to Capital Indaptus Therapeutics Inc (INDP)|SCNI (Scinai) - Short-Term Debt to Capital|Current Liabilities to Capital CalciMedica Corp CALI|Short-Term Debt to Equity Affimed (AFMD)|allakos.com (ALLK) - Short-Term Indebtedness to Equity|HOOKIPA Pharma - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital IGM Biosciences Inc. IGMS|iTeos - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Ocean Biomedical Corp OCEA|TC Biopharm (TCBP) - Short-Term Debt to Equity|THRD (thirdharmonicbio.com) - Short-Term Debt to Equity